Adenosine generation and signaling during acute kidney injury

Jessica D. Bauerle, Almut Grenz, Jae Hwan Kim, H. Thomas Lee, Holger K. Eltzschig

Research output: Contribution to journalShort survey

75 Citations (Scopus)

Abstract

Acute kidney injury (AKI) is among the leading causes of morbidity and mortality in hospitalized patients. Particularly in the perioperative period, the most common cause of AKI is renal ischemia. At present, therapeutic modalities to prevent or treat AKI are extremely limited and the search for novel therapeutic interventions for ischemic AKI is an area of intense investigation. Recent studies implicate the endogenous signaling molecule, adenosine, in kidney protection from ischemia. As such, enzymatic production of adenosine from its precursor molecules ATP and AMP, and signaling events through adenosine receptors, play a critical role in attenuating renal inflammation and preserving kidney function during episodes of renal ischemia. Utilizing genetic mouse models with defects in adenosine generation or signaling provide strong evidence for the key role of extracellular adenosine in adapting renal tissues to limited oxygen availability and attenuating hypoxiadriven inflammation of the kidneys. Moreover, experimental therapeutics targeting individual adenosine receptors demonstrate strong prophylactic or therapeutic effects during murine AKI. If these experimental strategies can be translated into a clinical setting, adenosine receptor therapeutics may become an integral part in the prevention or treatment of AKI from renal ischemia.

Original languageEnglish
Pages (from-to)14-20
Number of pages7
JournalJournal of the American Society of Nephrology
Volume22
Issue number1
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Acute Kidney Injury
Adenosine
Kidney
Purinergic P1 Receptors
Ischemia
Inflammation
Therapeutics
Perioperative Period
Genetic Models
Therapeutic Uses
Adenosine Monophosphate
Adenosine Triphosphate
Oxygen
Morbidity
Mortality

ASJC Scopus subject areas

  • Nephrology

Cite this

Adenosine generation and signaling during acute kidney injury. / Bauerle, Jessica D.; Grenz, Almut; Kim, Jae Hwan; Lee, H. Thomas; Eltzschig, Holger K.

In: Journal of the American Society of Nephrology, Vol. 22, No. 1, 01.01.2011, p. 14-20.

Research output: Contribution to journalShort survey

Bauerle, Jessica D. ; Grenz, Almut ; Kim, Jae Hwan ; Lee, H. Thomas ; Eltzschig, Holger K. / Adenosine generation and signaling during acute kidney injury. In: Journal of the American Society of Nephrology. 2011 ; Vol. 22, No. 1. pp. 14-20.
@article{e1b340243167498185c71460b6940b37,
title = "Adenosine generation and signaling during acute kidney injury",
abstract = "Acute kidney injury (AKI) is among the leading causes of morbidity and mortality in hospitalized patients. Particularly in the perioperative period, the most common cause of AKI is renal ischemia. At present, therapeutic modalities to prevent or treat AKI are extremely limited and the search for novel therapeutic interventions for ischemic AKI is an area of intense investigation. Recent studies implicate the endogenous signaling molecule, adenosine, in kidney protection from ischemia. As such, enzymatic production of adenosine from its precursor molecules ATP and AMP, and signaling events through adenosine receptors, play a critical role in attenuating renal inflammation and preserving kidney function during episodes of renal ischemia. Utilizing genetic mouse models with defects in adenosine generation or signaling provide strong evidence for the key role of extracellular adenosine in adapting renal tissues to limited oxygen availability and attenuating hypoxiadriven inflammation of the kidneys. Moreover, experimental therapeutics targeting individual adenosine receptors demonstrate strong prophylactic or therapeutic effects during murine AKI. If these experimental strategies can be translated into a clinical setting, adenosine receptor therapeutics may become an integral part in the prevention or treatment of AKI from renal ischemia.",
author = "Bauerle, {Jessica D.} and Almut Grenz and Kim, {Jae Hwan} and Lee, {H. Thomas} and Eltzschig, {Holger K.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1681/ASN.2009121217",
language = "English",
volume = "22",
pages = "14--20",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Adenosine generation and signaling during acute kidney injury

AU - Bauerle, Jessica D.

AU - Grenz, Almut

AU - Kim, Jae Hwan

AU - Lee, H. Thomas

AU - Eltzschig, Holger K.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Acute kidney injury (AKI) is among the leading causes of morbidity and mortality in hospitalized patients. Particularly in the perioperative period, the most common cause of AKI is renal ischemia. At present, therapeutic modalities to prevent or treat AKI are extremely limited and the search for novel therapeutic interventions for ischemic AKI is an area of intense investigation. Recent studies implicate the endogenous signaling molecule, adenosine, in kidney protection from ischemia. As such, enzymatic production of adenosine from its precursor molecules ATP and AMP, and signaling events through adenosine receptors, play a critical role in attenuating renal inflammation and preserving kidney function during episodes of renal ischemia. Utilizing genetic mouse models with defects in adenosine generation or signaling provide strong evidence for the key role of extracellular adenosine in adapting renal tissues to limited oxygen availability and attenuating hypoxiadriven inflammation of the kidneys. Moreover, experimental therapeutics targeting individual adenosine receptors demonstrate strong prophylactic or therapeutic effects during murine AKI. If these experimental strategies can be translated into a clinical setting, adenosine receptor therapeutics may become an integral part in the prevention or treatment of AKI from renal ischemia.

AB - Acute kidney injury (AKI) is among the leading causes of morbidity and mortality in hospitalized patients. Particularly in the perioperative period, the most common cause of AKI is renal ischemia. At present, therapeutic modalities to prevent or treat AKI are extremely limited and the search for novel therapeutic interventions for ischemic AKI is an area of intense investigation. Recent studies implicate the endogenous signaling molecule, adenosine, in kidney protection from ischemia. As such, enzymatic production of adenosine from its precursor molecules ATP and AMP, and signaling events through adenosine receptors, play a critical role in attenuating renal inflammation and preserving kidney function during episodes of renal ischemia. Utilizing genetic mouse models with defects in adenosine generation or signaling provide strong evidence for the key role of extracellular adenosine in adapting renal tissues to limited oxygen availability and attenuating hypoxiadriven inflammation of the kidneys. Moreover, experimental therapeutics targeting individual adenosine receptors demonstrate strong prophylactic or therapeutic effects during murine AKI. If these experimental strategies can be translated into a clinical setting, adenosine receptor therapeutics may become an integral part in the prevention or treatment of AKI from renal ischemia.

UR - http://www.scopus.com/inward/record.url?scp=78651411645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651411645&partnerID=8YFLogxK

U2 - 10.1681/ASN.2009121217

DO - 10.1681/ASN.2009121217

M3 - Short survey

VL - 22

SP - 14

EP - 20

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 1

ER -